Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-134828
Filing Date
2024-12-10
Accepted
2024-12-10 13:12:17
Documents
1
Period of Report
2024-12-09

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3189
  Complete submission text file 0000950170-24-134828.txt   4621
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Issuer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O RANI THERAPEUTICS HOLDINGS, INC. 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address
Imran Talat (Reporting) CIK: 0001869579 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40672 | Film No.: 241537838